🔎 Trials Near Me

Home › Multiple Myeloma › Rhode Island

Pag-aaral pangklinika para sa Multiple Myeloma sa Rhode Island

6 pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa mga site sa Rhode Island.

Mga Lungsod sa Rhode Island

Opisyal na teksto ng pag-aaral (English)

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

  • Rhode Island Hospital, Providence
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05552222

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  • Rodhe Island Hospital, Providence
  • The Miriam Hospital, Providence
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06152575

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

  • Smilow Cancer Hospital Care Center - Westerly, Westerly
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04566328

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

  • Smilow Cancer Hospital Care Center - Westerly, Westerly
Nagre-recruitPhase 3
Lahat ng edad · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT05561387

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

  • GSK Investigational Site, Providence
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT06679101

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

  • Rhode Island Hospital, Providence
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2025 · NCT06119685

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.